InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,481.40
(
0.15%
)
US TECH 100
19,395.60
(
-0.04%
)
Dow Jones
38,812.56
(
0.09%
)
Brent Oil
84.24
(
0.40%
)
Bitcoin
64,402.81
(
-3.13%
)
Post# of 252238
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: jq1234 post# 141126

Wednesday, 05/02/2012 5:54:39 AM

Wednesday, May 02, 2012 5:54:39 AM

Post# of 252238
PLX

Just heard their CEO talk and he said they are awaiting EU approval for Elelyso despite of Shire's orphan exclusivity there (for background see #msg-72258978). Another note is they are planning to enter the clinic with PRX-106 (anti-TNF fusion protein) later this year, despite of Amgen's new patent related to Enbrel.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up